A new treatment for prostate cancer developed and trialled in London has been licensed for use.
Enzalutamide was developed by researchers at the Royal Marsden and University College London hospitals.
The one a day pill checks the spread of the cancer.
Reseachers say the most exciting aspect of this new drug is that is has very few side effects- unlike many cancer treatements.
More top news
The hotel chain said three of its properties - in Maidenhead, Brentford and Tottenham - have been investigated during a detailed assessment
Leyton Orient have been in free-fall ever since Italian Becchetti bought the club from Barry Hearn in 2014.
A long-awaited report criticises industrial action taken by Aslef and the RMT union over the past year.